AAAAAA

   
Results: 1-13 |
Results: 13
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)
Authors: Najjar, F Hustinx, R Jerusalem, G Fillet, G Rigo, P
Citation: F. Najjar et al., Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL), CANC BIO R, 16(4), 2001, pp. 297-304
A simplified one-pot synthesis of 9-[(3-[F-18]fluoro-1-hydroxy-2-propoxy)methyl]guanine([F-18]FHPG) and 9-(4-[F-18]fluoro-3-hydroxymethylbutyl)guanine ([F-18]FHBG) for gene therapy
Authors: Shiue, GG Shiue, CY Lee, RL MacDonald, D Hustinx, R Eck, SL Alavi, AA
Citation: Gg. Shiue et al., A simplified one-pot synthesis of 9-[(3-[F-18]fluoro-1-hydroxy-2-propoxy)methyl]guanine([F-18]FHPG) and 9-(4-[F-18]fluoro-3-hydroxymethylbutyl)guanine ([F-18]FHBG) for gene therapy, NUCL MED BI, 28(7), 2001, pp. 875-883
Positron emission tomography (PET) with F-18-fluorodeoxyglucose (F-18-FDG)for the staging of low-grade non-Hodgkin's lymphoma (NHL)
Authors: Jerusalem, G Beguin, Y Najjar, F Hustinx, R Fassotte, MF Rigo, P Fillet, G
Citation: G. Jerusalem et al., Positron emission tomography (PET) with F-18-fluorodeoxyglucose (F-18-FDG)for the staging of low-grade non-Hodgkin's lymphoma (NHL), ANN ONCOL, 12(6), 2001, pp. 825-830
Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and [F-18]FHPG
Authors: Hustinx, R Shiue, CY Alavi, A McDonald, D Shiue, GG Zhuang, HM Lanuti, M Lambright, E Karp, JS Eck, SL
Citation: R. Hustinx et al., Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and [F-18]FHPG, EUR J NUCL, 28(1), 2001, pp. 5-12
An appraisal of 18-fluorodeoxyglucose positron emission tomography for melanoma staging
Authors: Paquet, P Henry, F Belhocine, T Hustinx, R Najjar, F Pierard-Franchimont, C Pierard, GE Rigo, P
Citation: P. Paquet et al., An appraisal of 18-fluorodeoxyglucose positron emission tomography for melanoma staging, DERMATOLOGY, 200(2), 2000, pp. 167-169
Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis
Authors: Hustinx, R Dolin, RJ Benard, F Bhatnagar, A Chakraborty, D Smith, RJ Jang, SY Alavi, A
Citation: R. Hustinx et al., Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis, EUR J NUCL, 27(9), 2000, pp. 1365-1371
Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis (vol 27, pg 1365, 2000)
Authors: Hustinx, R Dolin, RJ Benard, F Bhatnagar, A Chakraborty, D Smith, RJ Jang, S Alavi, A
Citation: R. Hustinx et al., Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis (vol 27, pg 1365, 2000), EUR J NUCL, 27(9), 2000, pp. 1435-1435
Nuclear imaging methods for non-invasive drug monitoring
Authors: Bhatnagar, A Hustinx, R Alavi, A
Citation: A. Bhatnagar et al., Nuclear imaging methods for non-invasive drug monitoring, ADV DRUG DE, 41(1), 2000, pp. 41-54
Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [F-18]EF1
Authors: Evans, SM Kachur, AV Shiue, CY Hustinx, R Jenkins, WT Shive, GG Karp, JS Alavi, A Lord, EM Dolbier, WR Koch, CJ
Citation: Sm. Evans et al., Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [F-18]EF1, J NUCL MED, 41(2), 2000, pp. 327-336
The role of positron emission tomography in the evaluation and staging of patients with recurrent colorectal carcinomas.
Authors: Hustinx, R Paulus, P Daenen, F Detroz, B Honore, P Jacquet, N Rigo, P
Citation: R. Hustinx et al., The role of positron emission tomography in the evaluation and staging of patients with recurrent colorectal carcinomas., GASTRO CL B, 23(3), 1999, pp. 323-329
Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Authors: Hustinx, R Smith, RJ Benard, F Bhatnagar, A Alavi, A
Citation: R. Hustinx et al., Can the standardized uptake value characterize primary brain tumors on FDG-PET?, EUR J NUCL, 26(11), 1999, pp. 1501-1509
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
Authors: Hustinx, R Smith, RJ Benard, F Rosenthal, DI Machtay, M Farber, LA Alavi, A
Citation: R. Hustinx et al., Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck, EUR J NUCL, 26(10), 1999, pp. 1345-1348
Potential applications of PET imaging in developing novel cancer therapies
Authors: Hustinx, R Eck, SL Alavi, A
Citation: R. Hustinx et al., Potential applications of PET imaging in developing novel cancer therapies, J NUCL MED, 40(6), 1999, pp. 995-1002
Risultati: 1-13 |